A STUDY OF SERUM AND FOLLICULAR FLUID C. REACTIVE PROTEIN AND ANTISPERM ANTIBODY AS PREDICTIVE MARKERS FOR HUMAN OOCYTE AND EMBRYO QUALITY AND ICSI OUTCOME.

- High Institute of Infertility Diagnosis and ART, Al-Nahrain University, Baghdad / Iraq.
- Collage of Medicine, Al-Nahrain University, Baghdad / Iraq.
- Kamal Al-Samarrai Hospital for Infertility Treatment/ BAGHDAD-IRAQ.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Background: C. reactive protein (CRP) is an acute phase reactant. Its level increases in infection, inflammation and following hormonal stimulation. While antisperm antibodies (ASA) cause immunological infertility through their affect on motility and capability of fertilization of spermatozoa which may negatively affect embryo development & implantation Objectives: To determine the predictive value of C. reactive protein (CRP) & Antisperm antibodies (ASA) detection in serum and follicular fluid for assessment of oocyte quality, embryo quality and ICSI outcome in patients using different stimulation protocols. Materials and Methods: Fifty eight (58) infertile women undergoing intra-cytoplasmic sperm injection cycles with an age of (21-41) years old were included in this study. C. reactive protein was measured in serum and follicular fluid by using agglutination and serial dilution method. Also an estimation of antisperm antibodies (ASA) levels in serum and follicular fluid was done by using ELISA. Results: The results of this study showed a significant negative correlation between the C. reactive protein& Anti-sperm antibodies levels in serum and follicular fluid with oocyte and embryo quality in all patients. Eighteen women (31%) achieved pregnancy (pregnant group), while forty women (69%) failed to achieve pregnancy (non-pregnant group). A significant difference was found in the concentration of C. reactive protein and antisperm antibodies in both serum and follicular fluid (P<0.05) between pregnant and non-pregnant groups. Conclusion: Serum and Follicular Fluid C. reactive protein and Anti-sperm antibodies are good predictors for oocyte quality, embryo quality and pregnancy rate in women undergoing IVF/ICSI cycles.
- Poppe K, Velkeniers B. thyroid and infertility. Verh. K. Geneeskd. Belg. 2002; 64(6): 389-99.
- Burney RO, Schust DJ, Yao MWM. Infertility. In: Berek JS (ed) Berek and Novak?s gynecology, 14th ed. Lippincott Williams and Wilkins, Philadelphia, 2007. pp 1185?1276.
- Evert JP, Van Santbrink, Bart CJM Fauser,et al. Ovulation induction in: Botros?? Rizk,? et al. Editors. Infertility and Assisted Reproduction. 1st New York. Cambridge University Press. 2008. pp. 193-201.
- Broekmans and Frank J. Prognostic testing for ovarian reserve.?Textbook of Assisted Reproductive Techniques Fourth Edition: Volume 2: Clinical Perspectives?50 (2012): 41.
- .Pepys MB and Hirschfeld GM. C-reactive protein: a critical update. J Clin Invest. 2003; 111: 1805- 1812.
- Ram Mohan Rao M. and Syam D Gopal. C-Reactive Protein - A critical Review. J.Curr.Microbiol.App.Sci. 2015; 4(12): 55-61.
- Valckx SD,?De Pauw I,?De Neubourg D,?Inion I,?Berth M,?Fransen E,?Bols PE,?Leroy JL. BMI-related metabolic composition of the follicular fluid of women undergoing assisted reproductive treatment and the consequences for oocyte and embryo quality. Hum Reprod 2012;27(12):353l-9.
- Karimi F, Khazaei S, Alaedini F. Serum antisperm anti-bodies in fertile and infertile individuals. Iran J Med Sci. 2008; 33 (2): 88-92.
- Rosenwaks C G. Reproductive Medicine Secrets. Antisperm antibodies in infertility.1st edition 2006; 41-48
- Ernest NG, Williams SB Yeung, Pak Chung HO. Oocyte and embryo quality in patients with excessive ovarian response during In vitro fertilization treatment; Assisted reproduction and genetics. 2003. P187.
- Des UN. ls obesity an inflammatory condition? Nutrition 2001.
- Ackerman SB, Graff D, van Uem JFHM, Swanson RJ, Veeck LL, Acosta AA, Garcia JE: Immunologic infertility and in vitro fertilization. Fertil Steril 42:474, 1984
- Clarke GN, McBain JC, Lopata A, Johnston WIH: In vitro fertilization results for women with sperm antibodies in plasma and follicular fluid. Am J Reprod Immunol 8:130, 1985
- Geoffrey Sher MD, Varginia M Davis RN,MN and Jean Stoess.MD. In vitro fertilization the ART of making babies assisted reproductive technology. 2013. P 156.
- Soheila Arefi, M.D., Mohammad Babashamsi, Poneh Shariat Panahi, Lima Asgharpour Saruiy, Hojjat Zeraati. C-reactive protein level and pregnancy rate in patients undergoing IVF/ICSI Iranian Journal of Reproductive Medicine. 2010; 8(4): 197-202.
- Miriam Almagor, Albert Hazav and Haim Yaffe. The levels of C-reactive protein in women treated by IVF Human Reproduction. 2004;19 (1): 104- 106.
- Costa LO, Mendes MC, Ferriani RA, Moura MD, Reis RM and Silva de S? MF. Estradiol and testosterone concentrations in follicular fluid as criteria to discriminate between mature and immature oocytes. Braz J Med Biol Res. 2004; 37:1747-55.
- Vazquez-Levin M, Kaplan P, Guzman I, Grunfeld L, Garrisi GJ, Navot D. The effect of female antisperm antibodies on in vitro fertilization, early embryonic development, and pregnancy outcome. Fertil Steril. 1991; 56(1):84-8.
- Pexieder T, Boillat E, Janecek P. Antisperm antibodies and in vitro fertilization failure. J. In Vitro Fert Embryo Transf.1985; 2 (4):229-32.
- Koji Nakagawa, Shyuji Yamano, Masaharu Kamada, Kenji Hinokio, Masahiko Maegawa, Toshihiro Aono Quality of embryo does not affect the implantation rate of IVF-ET in infertile women with antisperm antibody. Fertility and Sterility. 1999; 72 (6):1055-1060.
[Mohammad Oda Selman, Mufedah Ali Jawad, Ahmed R. Abu Raghif, Mustafa H.O. Hussein, Muayad Sraibet Abbood and Qays A. M. Al-khafaji. (2017); A STUDY OF SERUM AND FOLLICULAR FLUID C. REACTIVE PROTEIN AND ANTISPERM ANTIBODY AS PREDICTIVE MARKERS FOR HUMAN OOCYTE AND EMBRYO QUALITY AND ICSI OUTCOME. Int. J. of Adv. Res. 5 (Nov). 488-494] (ISSN 2320-5407). www.journalijar.com
High Institute of Infertility Diagnosis and ART, Al-Nahrain University, Baghdad / Iraq.